StockData

Drugs Made In America Acquisition Corp. (DMAA) stock

DMAANasdaqBlank ChecksFiscal year ends December 31Also trades as DMAAR, DMAAU
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.90+0.00 (0.00%)

Close on Nov 16, 2026Market cap $264.62MP/E –Yield –

Drugs Made In America Acquisition r&d expenses

Research and development expenses are spending on new products and technology.

No r&d expenses figures for Drugs Made In America Acquisition

Drugs Made In America Acquisition has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Drugs Made In America Acquisition figures

See a number that looks wrong?